Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study of Evaluating Safety and Efficacy of Tocilizumab Compared to Continuous Renal Replacement Therapy in Controlling CRS Triggered by COVID-19

NCT04306705 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT04306705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study of Evaluating Safety and Efficacy of Tocilizumab Compared to Continuous Renal Replacement Therapy in Controlling CRS Triggered by COVID-19
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 20, 2020
Completion date
June 20, 2020
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, cytokine release syndrome, cytokine storm, sars, tocilizumab